These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Eat less fat to prevent ischemic cardiopathy. The potential impact of population and individual strategies for controlling cholesterolemia in Spain]. Banegas Banegas JR; Rodríguez Artalejo F; Martín Moreno JM; del Rey Calero J Med Clin (Barc); 1993 Jun; 101(3):81-6. PubMed ID: 8315989 [TBL] [Abstract][Full Text] [Related]
3. [Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO]. Simoons ML; Casparie AF Ned Tijdschr Geneeskd; 1998 Sep; 142(38):2096-101. PubMed ID: 9856223 [TBL] [Abstract][Full Text] [Related]
4. [Clinical manifestations of familial hypercholesterolemia in Mediterranean population]. Alonso-Villaverde C; Sardà P; Vallbé JC; Heras M; Pérez-Jiménez F; Pedro-Botet JC; Ros-Rahola E; Masana L Med Clin (Barc); 1999 Oct; 113(14):521-5. PubMed ID: 10605666 [TBL] [Abstract][Full Text] [Related]
5. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial. Stender S; Schuster H; Barter P; Watkins C; Kallend D; Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130 [TBL] [Abstract][Full Text] [Related]
6. An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990. Law MR; Wald NJ Eur J Clin Nutr; 1994 May; 48(5):305-25. PubMed ID: 8055847 [TBL] [Abstract][Full Text] [Related]
7. Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study). Garmendia F; Brown AS; Reiber I; Adams PC Curr Med Res Opin; 2000; 16(3):208-19. PubMed ID: 11191012 [TBL] [Abstract][Full Text] [Related]
8. [Data on cholesterol level screening of patients with ischemic heart disease in the light of the Scandinavian Simvastatin Survival Study]. Márk L; Kondacs A; Hanyecz V; Simondán G Orv Hetil; 1997 Jun; 138(26):1679-82. PubMed ID: 9289681 [TBL] [Abstract][Full Text] [Related]
9. The effect of atorvastatin on serum lipoproteins in acromegaly. Mishra M; Durrington P; Mackness M; Siddals KW; Kaushal K; Davies R; Gibson M; Ray DW Clin Endocrinol (Oxf); 2005 Jun; 62(6):650-5. PubMed ID: 15943824 [TBL] [Abstract][Full Text] [Related]
10. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Law MR; Wald NJ; Thompson SG BMJ; 1994 Feb; 308(6925):367-72. PubMed ID: 8043072 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment. Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852 [TBL] [Abstract][Full Text] [Related]
12. [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure]. Stalenhoef AF Ned Tijdschr Geneeskd; 2006 Sep; 150(39):2127-30. PubMed ID: 17059084 [TBL] [Abstract][Full Text] [Related]
13. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E; Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231 [TBL] [Abstract][Full Text] [Related]
14. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin. Sampalis JS; Bissonnette S; Habib R; Boukas S; Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579 [TBL] [Abstract][Full Text] [Related]
15. Effect on hematologic risk factors for coronary heart disease of a cholesterol reducing diet. Jenkins DJ; Kendall CW; Nguyen TH; Teitel J; Marchie A; Chiu M; Taha AY; Faulkner DA; Kemp T; Wong JM; de Souza R; Emam A; Trautwein EA; Lapsley KG; Holmes C; Josse RG; Leiter LA; Singer W Eur J Clin Nutr; 2007 Apr; 61(4):483-92. PubMed ID: 17136042 [TBL] [Abstract][Full Text] [Related]
16. Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease. Farnier M; Volpe M; Massaad R; Davies MJ; Allen C Int J Cardiol; 2005 Jul; 102(2):327-32. PubMed ID: 15982505 [TBL] [Abstract][Full Text] [Related]
17. [Secondary prophylaxis in general practice for patients with ischemic heart disease]. Hamm LR; Bjerrum L; Aarslev PJ; Munck AP; Vach K; Kragstrup J Ugeskr Laeger; 2002 Jul; 164(27):3534-7. PubMed ID: 12116682 [TBL] [Abstract][Full Text] [Related]
18. Examination of encapsulated phytosterol ester supplementation on lipid indices associated with cardiovascular disease. Earnest CP; Mikus CR; Lemieux I; Arsenault BJ; Church TS Nutrition; 2007 Sep; 23(9):625-33. PubMed ID: 17644340 [TBL] [Abstract][Full Text] [Related]
19. [Statins in primary prevention of coronary heart disease]. Paulweber B Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004 [TBL] [Abstract][Full Text] [Related]
20. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002. Arnett DK; Jacobs DR; Luepker RV; Blackburn H; Armstrong C; Claas SA Circulation; 2005 Dec; 112(25):3884-91. PubMed ID: 16344385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]